Trade Summary

3 days ago, Lubner David Charles, serving as Dir at Braveheart Bio, Inc. (BRVE), purchased 55,555 shares at $18.00 per share, for a total transaction value of $999,990.00. Following this transaction, Lubner David Charles now holds 55,555 shares of BRVE.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 4:30 PM ET, meaning the disclosure happened on the same day as the trade.

Braveheart Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.